BSX Gross Margin Analysis

Gross margin measures the percentage of revenue a company keeps after paying direct production costs—here, 69.4% of every sales dollar remains after covering those costs.

This is nearly identical to the healthcare sector median of 69.8%, placing BSX at the 49th percentile among its peers, meaning it sits right around the middle of the industry. No year-over-year or quarter-over-quarter changes are available, so no trend in gross margin can be assessed. Because the current level is essentially at the sector average and there is no trend to indicate improvement or deterioration, the metric implies neither a clear risk nor a distinct opportunity. This neutral position directly supports the overall NEUTRAL verdict on the stock, as gross margin provides no reason to lean bullish or bearish.

Frequently Asked Questions